Skip to main content
. 2022 Jun 22;14(7):1319. doi: 10.3390/pharmaceutics14071319

Figure 7.

Figure 7

(A) Anti-biofilm activity graph for VOO-nanoformulations and their native ingredients against SA and EC, as compared to Cipro and DIW as a positive and negative control, respectively. (B) DPPH-RSA (%) for the same samples, ascorbic acid was used as a control.